DekaBank Deutsche Girozentrale - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$174,000
-39.8%
31,900
+10.0%
0.00%
-100.0%
Q4 2021$289,000
-41.0%
29,000
+2.8%
0.00%0.0%
Q3 2021$490,000
-25.6%
28,2000.0%0.00%
-50.0%
Q2 2021$659,000
-6.3%
28,2000.0%0.00%0.0%
Q1 2021$703,000
+238.0%
28,2000.0%0.00%
+100.0%
Q4 2020$208,000
+48.6%
28,2000.0%0.00%0.0%
Q3 2020$140,000
-69.4%
28,200
-2.8%
0.00%
-66.7%
Q4 2018$457,00029,0000.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders